Cite

    Benjamin R. Oshrine et al.. “Mixed chimerism and graft loss in pediatric recipients of an alemtuzumab‐based reduced‐intensity conditioning regimen for non‐malignant disease.” Pediatric blood & cancer, vol. 61, no. 10, n.d., pp. 1852–1859. http://access.bl.uk/ark:/81055/vdc_100025048006.0x000060